Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8VY4

Engineering a Tumor-Selective Prodrug T Cell Engager Bispecific Antibody for Safer Immunotherapy

Summary for 8VY4
Entry DOI10.2210/pdb8vy4/pdb
DescriptorFab Heavy Chain, Fab Light Chain, PCA-ASP-GLY-ASN-GLU-GLU-MET, ... (4 entities in total)
Functional Keywordsantibody, cd3, immune system
Biological sourceMus musculus
More
Total number of polymer chains3
Total formula weight47675.87
Authors
Antonysamy, S.,Demarest, S.,Froning, K.,Hickey, M.H.,Kuhlman, B.,McCue, A.C. (deposition date: 2024-02-06, release date: 2024-07-24)
Primary citationMcCue, A.C.,Demarest, S.J.,Froning, K.J.,Hickey, M.J.,Antonysamy, S.,Kuhlman, B.
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy.
Mabs, 16:2373325-2373325, 2024
Cited by
PubMed: 38962811
DOI: 10.1080/19420862.2024.2373325
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.7 Å)
Structure validation

222926

건을2024-07-24부터공개중

PDB statisticsPDBj update infoContact PDBjnumon